OmniComm will build and host the study for GLPI by installing TrialMaster for electronic data capture.
With the eLearning system, OmniComm will train more than 60 site users for the study and its EDC technology will help the GLPI to manage its complex clinical trial.
OmniComm chief executive officer Krzysztof Applet said Great Lakes Pharmaceuticals chose TrialMaster because it is a very straight-forward, configurable system with robust reporting capabilities.